#doseoptimization search results
Current dose optimization training is too generic. Let’s shift to personalized approaches—like adaptive paths, microlearning & simulations—to match the unique needs of radiologists, techs & physicians. Better training = better care. #DoseOptimization #RadiologyEducation
FDA’s Project Optimus is reshaping oncology dose selection to balance benefit and tolerability. For what this means in practice, IDDI’s podcast is a solid listen. linkedin.com/posts/iddi_fda… #IDDIPodcast #ProjectOptimus #doseoptimization #drugdevelopment #clinicaltrials
Discover how Qaelum enhances patient safety & workflow efficiency. Meet us at DGMP2025 (Sept 24–26, Berlin)! ✨ Don’t miss our live demos & scientific abstracts. qaelum.com/events/upcomin… #Radiology #PatientSafety #DoseOptimization #MedicalImaging
CT repeats = wasted dose, time, and cost. Qaelum’s FOQAL-CT Repeat turns inefficiencies into actionable insights — helping teams reduce repeat rates and optimize quality. 📊 Learn more → qaelum.com/news/news/towa… #CT #Radiology #DoseOptimization #Qaelum
Learned more in 3 hrs of convo with @PatLorusso and @KianLimWashU than I have for everything else during the past year combined, I think 🤩🤓🤩 #DevelopmentalTherapeutics #DoseOptimization
Proud to share our review in Cancer Treatment Reviews: We explore how trial designs are evolving to prioritize safety, biomarkers & patient-centered care. Thanks to Prof. @curijoey and @darioT_ #Oncology #DoseOptimization #CancerTrials @OncoAlert
🌟 BRAND NEW 🌟 60-second animated abstract! This one summarizes a manuscript on #doseoptimization I recently published in the @Cancers_MDPI special issue, “Research on Targeted Drugs in Cancer”. Check out the full-length paper here: mdpi.com/2072-6694/16/1… #targetedtherapy
#DoseOptimization in Oncology Drugs - a 🧵 #bcsm 1/ “The modern drug development paradigm in oncology should recognize that the MTD is not necessarily the optimal dose… phase I trials should determine a range of dosages.” —FDA/ASCO guidance (July 2025) 👉 raps.org
This report by AgencyIQ on the FDA's dose optimization guidance for oncology products provides insights into the contrasting viewpoints of regulators, researchers, patients, and industry. Read the full article here: ow.ly/HZZu50OzHHW #FDAguidance #DoseOptimization
"Moving the Needle for Oncology Dose Optimization: A Call for Action" highlights the importance of adaptive dosing strategies to improve treatment efficacy and patient outcomes in #oncology. Read the article: bit.ly/3zpAL4K #DoseOptimization
#FDA proposes new guidance for #doseoptimization in #cancerdrugs for #clinicaltrials. Aims to identify optimal doses before regulatory submissions for approval #PMWC23 more on January 25-27 in Track 2 Chaired by @williamohmd, download FDA draft guidance bit.ly/3XWj9V7
🎯 Join us for AsiaSafe’s 3rd webinar in the 2025 series: Optimizing Dose in Interventional Radiology – Tools & Techniques! Learn global best practices on Aug 2 | 🕗 5:30 PM IST | 8:00 AM USA ET 🔗 Register: aosr.vidocto.com #AsiaSafe #PatientSafety #DoseOptimization
Friends supports the development of oncology treatments that are not only safe and effective, but also tolerable. Learn about Friends #DoseOptimization and #Tolerability work. trib.al/fBZUlaq
Great news that #therightdose #doseoptimization is gaining steam!
Speaking on #doseoptimization, “We want to live as long as possible, but not at any price,” said Julia Maues (@itsnot_pink) who has #metastaticbreastcancer. “What we want is to balance treatment with quality of life.” therightdose.org #bcsm cancer.gov/news-events/ca…
This👉🏻“No camizestrant dose reduction or discontinuation secondary to TRAEs was reported for doses of 150 mg and below.” With similar ORR, CBR, mPFS @ lower doses. Hopeful Camizestrant cont’s to show promise for HR+ MBC! #DoseOptimization #QoL #bcsm #metastaticbreastcancer
I obviously quote tweeted another @Annals_Oncology article 😅 x.com/aftimosp/statu… #bcsm #ESMOBreast24
A #doseoptimization approach that leverages technological advancements and follows the most current regulatory guidelines can help save patients from unnecessary exposures and adverse effects – helping unlock the full clinical benefit of a treatment. hubs.li/Q01FGdWJ0
🧵 Evaluating the Impact of a Dose-Optimization App on Zestril Efficacy for Hypertension Management #Zestril #Hypertension #DoseOptimization #App #ClosedLoopTesting #Efficacy #BloodPressureManagement
Selecting the optimal dosage requires a robust understanding of a therapy’s efficacy, safety, and tolerability. Visit Friends tolerability page to learn more about our work in this critical space. friendsofcancerresearch.org/tolerability/ #FriendsDosing #DoseOptimization
Dr. Patricia LoRusso, “make every patient count & make the drug count in every patient!” #DoseOptimization #PCDI @The_Right_Dose #bcsm @SABCSSanAntonio #SABCS24
#DoseOptimization “It's the right thing to do for our patients,” says Mikkael Sekeres, MD. Does drug $$ matter? “Each milligram of drug doesn't have an inherent value.” Optimal dosing w/⬇️toxicities, pts are likely to remain on tx longer= win/win! #bcsm medpagetoday.com/opinion/second…
medpagetoday.com
Opinion | Ending Oncology's Toxic Relationship With High Chemotherapy Doses
Optimizing doses can improve patient outcomes and lower costs
CT repeats = wasted dose, time, and cost. Qaelum’s FOQAL-CT Repeat turns inefficiencies into actionable insights — helping teams reduce repeat rates and optimize quality. 📊 Learn more → qaelum.com/news/news/towa… #CT #Radiology #DoseOptimization #Qaelum
FDA’s Project Optimus is reshaping oncology dose selection to balance benefit and tolerability. For what this means in practice, IDDI’s podcast is a solid listen. linkedin.com/posts/iddi_fda… #IDDIPodcast #ProjectOptimus #doseoptimization #drugdevelopment #clinicaltrials
Discover how Qaelum enhances patient safety & workflow efficiency. Meet us at DGMP2025 (Sept 24–26, Berlin)! ✨ Don’t miss our live demos & scientific abstracts. qaelum.com/events/upcomin… #Radiology #PatientSafety #DoseOptimization #MedicalImaging
Discover how Qaelum enhances patient safety & workflow efficiency. Meet us at DGMP2025 (Sept 24–26, Berlin)! ✨ Don’t miss our live demos & scientific abstracts. qaelum.com/events/upcomin… #Radiology #PatientSafety #DoseOptimization #MedicalImaging
#DoseOptimization in Oncology Drugs - a 🧵 #bcsm 1/ “The modern drug development paradigm in oncology should recognize that the MTD is not necessarily the optimal dose… phase I trials should determine a range of dosages.” —FDA/ASCO guidance (July 2025) 👉 raps.org
4/ Dosing isn’t just a science issue. It’s a quality of life issue—especially for people on treatment for the long haul. Read the article online ascopubs.org/doi/full/10.12… #DoseOptimization #MBC #Oncology 🧵
🎯 Join us for AsiaSafe’s 3rd webinar in the 2025 series: Optimizing Dose in Interventional Radiology – Tools & Techniques! Learn global best practices on Aug 2 | 🕗 5:30 PM IST | 8:00 AM USA ET 🔗 Register: aosr.vidocto.com #AsiaSafe #PatientSafety #DoseOptimization
Current dose optimization training is too generic. Let’s shift to personalized approaches—like adaptive paths, microlearning & simulations—to match the unique needs of radiologists, techs & physicians. Better training = better care. #DoseOptimization #RadiologyEducation
🔟 Action needed on dose titration! 🔊 Loud message: Starting therapy isn’t enough—optimize dosing continuously to ensure max benefits. #DoseOptimization #GDMT [11/11]
Proud to share our review in Cancer Treatment Reviews: We explore how trial designs are evolving to prioritize safety, biomarkers & patient-centered care. Thanks to Prof. @curijoey and @darioT_ #Oncology #DoseOptimization #CancerTrials @OncoAlert
Proud to share our review in Cancer Treatment Reviews: We explore how trial designs are evolving to prioritize safety, biomarkers & patient-centered care. Thanks to @DarioTrapani & Prof. @curijoey ! #Oncology #DoseOptimization #CancerTrials sciencedirect.com/science/articl…
SABCS 2024 | Clinical Symposium on Dose Optimization and Regimen Design in Breast Oncology mediamedic.co/sabcs-2024-cli… linkedin.com/pulse/sabcs-20… #SABCS2024 #BreastOncology #DoseOptimization
A new era in dosing for people with #breastcancer. #doseoptimization helps people stay on treatment longer and miss less. Get the latest from #SABCS24. bit.ly/3ZDJgCK “We don’t just want to live long. We want to live well.” - Julia Maués, co-founder of @the_rightdose
Excited to support my friend, & #PCDI lead @itsnot_pink as she represents @The_Right_Dose, bringing invaluable patient expertise on #doseoptimization to #SABCS24! Changing the conversation, moving away from #MTD, toward #PersonalizedMedicine in #Oncology. #SABCS24…
Dr. Patricia LoRusso, “make every patient count & make the drug count in every patient!” #DoseOptimization #PCDI @The_Right_Dose #bcsm @SABCSSanAntonio #SABCS24
Proud to share our review in Cancer Treatment Reviews: We explore how trial designs are evolving to prioritize safety, biomarkers & patient-centered care. Thanks to Prof. @curijoey and @darioT_ #Oncology #DoseOptimization #CancerTrials @OncoAlert
Learned more in 3 hrs of convo with @PatLorusso and @KianLimWashU than I have for everything else during the past year combined, I think 🤩🤓🤩 #DevelopmentalTherapeutics #DoseOptimization
Friends supports the development of oncology treatments that are not only safe and effective, but also tolerable. Learn about Friends #DoseOptimization and #Tolerability work. trib.al/fBZUlaq
We have made “significant progress in more hope for patients.” But “patients deserve a more tolerable dose.” Atik Rahman, Director, Division of Cancer Pharmacology II, @FDAOncology #DoseOptimization Join #FriendsAM21 live: trib.al/N7ZIoIG
A new era in dosing for people with #breastcancer. #doseoptimization helps people stay on treatment longer and miss less. Get the latest from #SABCS24. bit.ly/3ZDJgCK “We don’t just want to live long. We want to live well.” - Julia Maués, co-founder of @the_rightdose
Dose optimization is a critical aspect of oncology drug development and requires stakeholder coordination to ensure patients receive the appropriate #dose. The #DoseOptimization panel from our Annual Meeting answered outstanding questions in our blog post trib.al/R2PSCwR
Selecting the optimal dosage requires a robust understanding of a therapy’s efficacy, safety, and tolerability. Visit Friends tolerability page to learn more about our work in this critical space. friendsofcancerresearch.org/tolerability/ #FriendsDosing #DoseOptimization
#FDA proposes new guidance for #doseoptimization in #cancerdrugs for #clinicaltrials. Aims to identify optimal doses before regulatory submissions for approval #PMWC23 more on January 25-27 in Track 2 Chaired by @williamohmd, download FDA draft guidance bit.ly/3XWj9V7
Listening to the @CancerResrch annual meeting and so glad Anne Loeser of @the_rightdose is providing the patient viewpoint on dose optimization. More is often just more, not better. #bcsm #DoseOptimization #FriendsAM21
Join #FriendsAM21 live: Panel Discussion on Maximizing Benefit and Improving Tolerability for Patients Through #DoseOptimization. trib.al/N7ZIoIG featuring: Mark Ratain @UChicago Lokesh Jain @Merck Anne Loeser, Mirat Shah, CDER, @US_FDA Laurie Strawn @pfizer
A critical part of understanding the value of a new #therapy is identifying the safety and efficacy of the product. Learn about Friends #DoseOptimization and #Tolerability work. friendsofcancerresearch.org/tolerability/
Dr. Patricia LoRusso, “make every patient count & make the drug count in every patient!” #DoseOptimization #PCDI @The_Right_Dose #bcsm @SABCSSanAntonio #SABCS24
“What do we do with awareness? Because it’s not enough. We need a strategic database solution.” #oncology Annie Loeser @mbcalliance member. #DoseOptimization Join #FriendsAM21 live: trib.al/N7ZIoIG f
Excited to support my friend, & #PCDI lead @itsnot_pink as she represents @The_Right_Dose, bringing invaluable patient expertise on #doseoptimization to #SABCS24! Changing the conversation, moving away from #MTD, toward #PersonalizedMedicine in #Oncology. #SABCS24…
Attending #ASHP20? @Kuperrx highlights exciting #doseoptimization presentations that you shouldn't miss in our latest blog. loom.ly/QPgBxB4
This report by AgencyIQ on the FDA's dose optimization guidance for oncology products provides insights into the contrasting viewpoints of regulators, researchers, patients, and industry. Read the full article here: ow.ly/HZZu50OzHHW #FDAguidance #DoseOptimization
🆕in #JAC "Pragmatic options for #doseOptimization of ceftazidime/avibactam with aztreonam in complex patients" academic.oup.com/jac/advance-ar…
About half oncologists who responded to @ASCO's survey agreed that patients should start at a lower than the approved dose, and increase if well-tolerated. #doseoptimization #startlowgoslow ascopubs.org/doi/10.1200/OP…
“..it’s unacceptable for patients to experience chronic low grade nausea or diarrhea..” Dr. LoRusso @YaleCancer. Excellent presentations & possible ways to improve #doseoptimization by #AACRSciencePolicy @FDAOncology #bcsm @the_rightdose
🎯 Join us for AsiaSafe’s 3rd webinar in the 2025 series: Optimizing Dose in Interventional Radiology – Tools & Techniques! Learn global best practices on Aug 2 | 🕗 5:30 PM IST | 8:00 AM USA ET 🔗 Register: aosr.vidocto.com #AsiaSafe #PatientSafety #DoseOptimization
Something went wrong.
Something went wrong.
United States Trends
- 1. #UFC322 52.7K posts
- 2. Bo Nickal 5,359 posts
- 3. Georgia 76.5K posts
- 4. Bama 20.5K posts
- 5. Ewing 6,776 posts
- 6. #AEWCollision 8,809 posts
- 7. Arch 19.5K posts
- 8. Ole Miss 8,024 posts
- 9. Wingo 2,003 posts
- 10. UConn 6,142 posts
- 11. Oklahoma 31.6K posts
- 12. Bronny 6,956 posts
- 13. Sark 2,533 posts
- 14. Wellmaker 4,717 posts
- 15. Cash Jones N/A
- 16. #Svengoolie 1,941 posts
- 17. James Peoples 1,204 posts
- 18. Tracy Cortez 2,280 posts
- 19. Lebby N/A
- 20. Ahmad Hardy N/A